These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37947389)

  • 1. The tumor immune microenvironment in pancreatic cancer and its potential in the identification of immunotherapy biomarkers.
    Tsunedomi R; Shindo Y; Nakajima M; Yoshimura K; Nagano H
    Expert Rev Mol Diagn; 2023; 23(12):1121-1134. PubMed ID: 37947389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer.
    Ge W; Yue M; Wang Y; Wang Y; Xue S; Shentu D; Mao T; Zhang X; Xu H; Li S; Ma J; Wang L; Cui J
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer.
    Yu Y; Schuck K; Friess H; Kong B
    Expert Opin Ther Targets; 2021 Jan; 25(1):5-13. PubMed ID: 33246383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast heterogeneity in pancreatic ductal adenocarcinoma: Perspectives in immunotherapy.
    Luong T; Golivi Y; Nagaraju GP; El-Rayes BF
    Cytokine Growth Factor Rev; 2022 Dec; 68():107-115. PubMed ID: 36096869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives.
    Toledo B; Deiana C; Scianò F; Brandi G; Marchal JA; Perán M; Giovannetti E
    Expert Rev Clin Pharmacol; 2024 Apr; 17(4):323-347. PubMed ID: 38413373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
    Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
    Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer.
    Du J; Chen Y; Liu G; Zeng Q; Zhou N; Du D
    Pathol Res Pract; 2023 Mar; 243():154374. PubMed ID: 36801507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do novel treatment strategies enhance T cell-mediated Immunity: Opportunities and challenges in pancreatic cancer immunotherapy.
    Luo W; Zheng L; Zhang T
    Int Immunopharmacol; 2021 Jan; 90():107199. PubMed ID: 33246828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer.
    Chen Y; Wang C; Song J; Xu R; Ruze R; Zhao Y
    Front Immunol; 2021; 12():758004. PubMed ID: 34887861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Tango between Cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in Pancreatic Cancer.
    Stouten I; van Montfoort N; Hawinkels LJAC
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment.
    Boyd LNC; Andini KD; Peters GJ; Kazemier G; Giovannetti E
    Semin Cancer Biol; 2022 Jul; 82():184-196. PubMed ID: 33737108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive prognostic and immune analysis of a glycosylation related risk model in pancreatic cancer.
    Liu X; Shi J; Tian L; Xiao B; Zhang K; Zhu Y; Zhang Y; Jiang K; Zhu Y; Yuan H
    BMC Cancer; 2023 Dec; 23(1):1229. PubMed ID: 38097951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles in pancreatic cancer immune escape: Emerging roles and mechanisms.
    Liu C; He D; Li L; Zhang S; Wang L; Fan Z; Wang Y
    Pharmacol Res; 2022 Sep; 183():106364. PubMed ID: 35901939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined MEK and STAT3 Inhibition Uncovers Stromal Plasticity by Enriching for Cancer-Associated Fibroblasts With Mesenchymal Stem Cell-Like Features to Overcome Immunotherapy Resistance in Pancreatic Cancer.
    Datta J; Dai X; Bianchi A; De Castro Silva I; Mehra S; Garrido VT; Lamichhane P; Singh SP; Zhou Z; Dosch AR; Messaggio F; Ban Y; Umland O; Hosein PJ; Nagathihalli NS; Merchant NB
    Gastroenterology; 2022 Dec; 163(6):1593-1612. PubMed ID: 35948109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
    Liu H; Shi Y; Qian F
    Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune checkpoint blockade in pancreatic cancer: Trudging through the immune desert.
    Li X; Gulati M; Larson AC; Solheim JC; Jain M; Kumar S; Batra SK
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):14-27. PubMed ID: 36041672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated multi-omics identified the novel intratumor microbiome-derived subtypes and signature to predict the outcome, tumor microenvironment heterogeneity, and immunotherapy response for pancreatic cancer patients.
    Zhang B; Liu J; Li H; Huang B; Zhang B; Song B; Bao C; Liu Y; Wang Z
    Front Pharmacol; 2023; 14():1244752. PubMed ID: 37745080
    [No Abstract]   [Full Text] [Related]  

  • 19. Nano-Drug Delivery Systems Targeting CAFs: A Promising Treatment for Pancreatic Cancer.
    Wang M; Xue W; Yuan H; Wang Z; Yu L
    Int J Nanomedicine; 2024; 19():2823-2849. PubMed ID: 38525013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing chemotherapy for pancreatic cancer through efficient and sustained tumor microenvironment remodeling with a fibroblast-targeted nanosystem.
    Zhou X; Zhang P; Liu N; Zhang X; Lv H; Xu W; Huo M
    J Control Release; 2023 Sep; 361():161-177. PubMed ID: 37536546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.